These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3297334)

  • 21. Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites.
    Goodacre JA; Middleton S; Lynn S; Ross DA; Pearson J
    Immunology; 1993 Apr; 78(4):586-91. PubMed ID: 8388364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
    Schluesener H; Brunner C; Vass K; Lassmann H
    J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete Freund's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice.
    Ratkay LG; Zhang L; Tonzetich J; Waterfield JD
    J Immunol; 1993 Nov; 151(9):5081-7. PubMed ID: 8409458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
    J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cartilage proteoglycans as T cell autoantigens.
    Goodacre JA; Pearson JP
    Ann Rheum Dis; 1992 Sep; 51(9):1094-7. PubMed ID: 1384442
    [No Abstract]   [Full Text] [Related]  

  • 28. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
    Buzás EI; Végvári A; Murad YM; Finnegan A; Mikecz K; Glant TT
    Cell Immunol; 2005 Jun; 235(2):98-108. PubMed ID: 16185673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of gammadelta T cells by mycobacterial antigens in rheumatoid arthritis.
    Holoshitz J
    Microbes Infect; 1999 Mar; 1(3):197-202. PubMed ID: 10801230
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant arthritis: immunopathological and hyperalgesic features.
    Rosenthale ME; Capetola RJ
    Fed Proc; 1982 Jul; 41(9):2577-82. PubMed ID: 6177558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infectious origin of rheumatoid arthritis].
    Youinou P; Lamour A; Dueymes M; Le Goff P
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):30S-35S. PubMed ID: 8162006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The virus-activated suppressor cell hypothesis in experimental and human rheumatic diseases.
    Kapusta MA
    J Rheumatol; 1980; 7(3):309-15. PubMed ID: 6157023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental rheumatoid arthritis].
    Siniachenko OV; Barinov EF; Ziablitsev SV; Kishenia MS; Iaglenko VV
    Revmatologiia (Mosk); 1991; (3):36-40. PubMed ID: 1812562
    [No Abstract]   [Full Text] [Related]  

  • 34. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis.
    Myers LK; Seyer JM; Stuart JM; Terato K; David CS; Kang AH
    J Immunol; 1993 Jul; 151(1):500-5. PubMed ID: 7686947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards T cell vaccination in rheumatoid arthritis.
    van Laar JM; Miltenburg AM; Breedveld FC; Cohen IR; de Vries RR
    Chem Immunol; 1994; 58():206-35. PubMed ID: 8011153
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral toleragens in rheumatoid arthritis.
    Choy EH
    Curr Opin Investig Drugs; 2000 Sep; 1(1):58-62. PubMed ID: 11249596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Various problems of immunopathology of rheumatoid arthritis].
    Lozovoĭ VP; Shirinskiĭ VS
    Ter Arkh; 1981; 53(3):33-42. PubMed ID: 6973218
    [No Abstract]   [Full Text] [Related]  

  • 38. Superantigens and their role in autoimmune disorders.
    Schiffenbauer J
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):17-24. PubMed ID: 11729824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cartilage proteoglycan-specific T cells as vectors of immunomodulatory biologicals in chronic proteoglycan-induced arthritis.
    Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Lafeber FP; Broeren CP; van Eden W; Broere F
    Mol Immunol; 2008 Aug; 45(13):3526-35. PubMed ID: 18579208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the homing of Mycobacterium-sensitized T lymphocytes to the synovium during passive adjuvant arthritis.
    DeJoy SQ; Ferguson-Chanowitz K; Oronsky AL; Zabriskie JB; Kerwar SS
    Cell Immunol; 1990 Oct; 130(1):195-203. PubMed ID: 2118831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.